This study tests a weekly injection called pemvidutide in 100 overweight or obese adults with moderate-to-severe alcohol use disorder. The goal is to see if it reduces the number of heavy drinking days compared to a placebo. Participants receive either the drug or a placebo for 2…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 17, 2026 14:23 UTC